VANCOUVER, British Columbia, Nov. 12, 2012 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, announced that it will hold a conference call and webcast on Tuesday, November 13, 2012 at 4:30 am Pacific Time (7:30 am Eastern Time) to provide a corporate update and report financial and operating results for the third quarter ended September 30, 2012.

Conference Call and Webcast Information

A live webcast of the call can be accessed through the Investor section of Tekmira's website at www.tekmirapharm.com. Or, alternatively, to access the conference call, please dial 914-495-8556 or 1-866-393-1607 and reference conference ID 70796137.

An archived webcast will be available on the Tekmira website approximately two hours after the event. Alternatively, to access a replay of the conference call, please dial 404-537-3406 or 1-855-859-2056 and reference conference ID 70796137.

About Tekmira

Tekmira Pharmaceuticals Corporation is a biopharmaceutical company focused on advancing novel RNAi therapeutics and providing its leading lipid nanoparticle delivery technology to pharmaceutical partners. Tekmira has been working in the field of nucleic acid delivery for over a decade and has broad intellectual property covering LNPs. Further information about Tekmira can be found at www.tekmirapharm.com. Tekmira is based in Vancouver, B.C.

The Tekmira Pharmaceuticals logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=8319

CONTACT: Investors

         Jodi Regts

         Director, Investor Relations

         Phone: 604-419-3234

         Email: jregts@tekmirapharm.com



         Media

         David Ryan 

         Longview Communications Inc. 

         Phone: 416-649-8007

         Email: dryan@longviewcomms.ca